SouthWest NanoTechnologies to Demonstrate Carbon Nanotube Inks and Fabrics at MRS

SouthWest NanoTechnologies, Inc. (SWeNT), the world leader in high quality, Single-Wall and Specialty-Multi-Wall carbon nanotubes (CNT), will demonstrate innovative, new CNT inks and nano fabrics at the 2010 Material Research Society (MRS) Spring Meeting, April 5-9 at the Moscone West and San Francisco Marriott. (Booth #526).

SWeNT's new nanoPly fabric is layered with large quantities of carbon nanotubes that can either be electrically-conductive -- suitable for sensing in structural composite applications -- or formulated to enhance composite structure strength. The pre-fabricated nanoPly product eliminates onsite mixing of resins and nanotubes which minimizes safety concerns and viscosity issues.

"The nanoPly coated fabrics can be customized for a wide range of applications, particularly alternative energy and infrastructure-related projects," explains SWeNT CEO Dave Arthur.

SWeNT will also be exhibiting its CNT Inks based on V2V Ink Technology developed by alliance partner, Chasm Technologies, Inc. With V2V, for the first time, carbon nanotubes can be printed using commercial, high-volume printing methods and equipment, including flexographic, gravure and screen printing. This breakthrough ink technology, combined with SWeNT's unique ability to tailor the synthesis of CNT materials for applications (using its patented CoMoCAT process) will enable customers to print large area, low-cost devices for a wide range of applications including energy-efficient lighting, affordable photovoltaics, improved energy storage and printed electronics.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.